ESPR vs AAPL: Which Stock is Better?
Side-by-side comparison of Esperion Therapeutics Inc and Apple Inc in 2026
ESPR
Esperion Therapeutics Inc
$3.18
AAPL
Apple Inc
$325.13
Key Metrics Comparison
| Metric | ESPR | AAPL | Winner |
|---|---|---|---|
| Market Cap | $816.89M | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | AAPL |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 69.1% | 7.9% | ESPR |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze ESPR
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ESPR or AAPL a better investment?
Comparing ESPR and AAPL: Esperion Therapeutics Inc has a market cap of $816.89M while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ESPR and AAPL?
ESPR (Esperion Therapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ESPR or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ESPR or AAPL?
ESPR has higher revenue growth at 69.1% vs 7.9% for AAPL.
Which company is more profitable: ESPR or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for ESPR.
Which is the larger company: ESPR or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $816.89M for ESPR.
Should I buy ESPR or AAPL in 2026?
Both ESPR and AAPL have investment merit. ESPR trades at $3.18 while AAPL trades at $325.13. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ESPR and AAPL stock?
Key differences: Market Cap ($816.89M vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (69.1% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy ESPR or AAPL in 2026?
The choice between ESPR and AAPL depends on your investment goals. ESPR shows higher revenue growth (69.1%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ESPR and AAPL?
ESPR (Esperion Therapeutics Inc) has a market cap of $816.89M, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.